N1-Methyl-lysergic acid diethylamide
Systematic (IUPAC) name | |
---|---|
(8β)-N,N-Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide | |
Clinical data | |
Oral | |
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
4238-85-1 | |
PubChem | CID 165200 |
ChemSpider | 144824 |
Synonyms | MLD-41, N1- Methyl- Lysergic Acid Diethylamide |
Chemical data | |
Formula | C21H27N3O |
337.47 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD.
Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals.[1]
References
- ↑ Müller-Schweinitzer and Tapparelli (1986). Methylergometrine, an active metabolite of methysergide. Cephalalgia. 6: 35-41.